Fuyan Xu

487 total citations
12 papers, 364 citations indexed

About

Fuyan Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Fuyan Xu has authored 12 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Fuyan Xu's work include Autophagy in Disease and Therapy (3 papers), Brain Metastases and Treatment (3 papers) and MicroRNA in disease regulation (2 papers). Fuyan Xu is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), Brain Metastases and Treatment (3 papers) and MicroRNA in disease regulation (2 papers). Fuyan Xu collaborates with scholars based in China, United States and Hong Kong. Fuyan Xu's co-authors include Yong Xia, Qiang Xue, Luoting Yu, Tinghong Ye, Yiqian Zhang, Meng‐Ling Wu, Wentao Lin, Ranran Wang, Hongbo Ma and Yufei Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Fuyan Xu

11 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fuyan Xu China	7	241	101	87	50	42	12	364
Tatsuhiko Shigeto Japan	12	265 1.1×	122 1.2×	76 0.9×	77 1.5×	23 0.5×	24	474
Boh-Ram Kim South Korea	13	248 1.0×	79 0.8×	22 0.3×	63 1.3×	26 0.6×	17	345
Leiming Wang China	11	274 1.1×	120 1.2×	57 0.7×	61 1.2×	19 0.5×	14	372
Zhanzhan Feng China	14	273 1.1×	35 0.3×	38 0.4×	102 2.0×	21 0.5×	19	395
Virginie Quidville France	8	228 0.9×	129 1.3×	44 0.5×	88 1.8×	30 0.7×	10	398
Dongmei Guo China	13	276 1.1×	106 1.0×	33 0.4×	77 1.5×	27 0.6×	35	409
Xiaoxue Qin China	10	214 0.9×	110 1.1×	94 1.1×	63 1.3×	14 0.3×	21	356
Weihao Chen China	9	146 0.6×	66 0.7×	70 0.8×	62 1.2×	33 0.8×	25	317
Shuanying Yang China	10	150 0.6×	64 0.6×	62 0.7×	79 1.6×	23 0.5×	22	312

Countries citing papers authored by Fuyan Xu

Since Specialization

Citations

This map shows the geographic impact of Fuyan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuyan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuyan Xu more than expected).

Fields of papers citing papers by Fuyan Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuyan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuyan Xu. The network helps show where Fuyan Xu may publish in the future.

Co-authorship network of co-authors of Fuyan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Fuyan Xu. A scholar is included among the top collaborators of Fuyan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuyan Xu. Fuyan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Xu, Fuyan, Anqi He, Ru Li, et al.. (2025). Repurposing chlorpromazine for the treatment of triple-negative breast cancer growth and metastasis based on modulation of mitochondria-mediated apoptosis and autophagy/mitophagy. British Journal of Cancer. 132(11). 997–1009. 2 indexed citations

Li, Zhang, Yang Yang, Wenrong Liu, et al.. (2025). A Circular RNA Promotes Tumor Metastasis through Stabilizing MSI2 Protein in Pancreatic Ductal Adenocarcinoma. Research. 8. 918–918.

Xu, Fuyan, Jiao Li, Min Ai, et al.. (2024). Penfluridol inhibits melanoma growth and metastasis through enhancing von Hippel‒Lindau tumor suppressor‐mediated cancerous inhibitor of protein phosphatase 2A (CIP2A) degradation. SHILAP Revista de lepidopterología. 5(10). e758–e758. 1 indexed citations

Ai, Min, Fuyan Xu, Yue Ming, et al.. (2024). Targeting oncogenic transcriptional factor c-myc by oligonucleotide PROTAC for the treatment of hepatocellular carcinoma. European Journal of Medicinal Chemistry. 280. 116978–116978. 6 indexed citations

Chen, Shuang, Ke Li, Jiawei Guo, et al.. (2023). circNEIL3 inhibits tumor metastasis through recruiting the E3 ubiquitin ligase Nedd4L to degrade YBX1. Proceedings of the National Academy of Sciences. 120(13). e2215132120–e2215132120. 57 indexed citations

Xu, Fuyan, Yiqian Zhang, Hongbo Ma, et al.. (2022). Repurposed antipsychotic chlorpromazine inhibits colorectal cancer and pulmonary metastasis by inducing G2/M cell cycle arrest, apoptosis, and autophagy. Cancer Chemotherapy and Pharmacology. 89(3). 331–346. 26 indexed citations

Liu, Xuan, Yiqian Zhang, Fuyan Xu, et al.. (2022). Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer. Frontiers in Pharmacology. 13. 909821–909821. 53 indexed citations

Xia, Yong, Fuyan Xu, Meiping Xiong, et al.. (2020). Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux. Pharmacological Research. 163. 105295–105295. 61 indexed citations

Xu, Fuyan, Weixi Xiong, Yiman Huang, et al.. (2019). Structural basis for efonidipine block of a voltage-gated Ca2+ channel. Biochemical and Biophysical Research Communications. 513(3). 631–634. 2 indexed citations

10.

Xia, Yong, Qiang Xue, Yao Xie, et al.. (2019). Antipsychotic Drug Trifluoperazine Suppresses Colorectal Cancer by Inducing G0/G1 Arrest and Apoptosis. Frontiers in Pharmacology. 10. 1029–1029. 47 indexed citations

11.

Xu, Fuyan, Yong Xia, Zhanzhan Feng, et al.. (2019). Repositioning antipsychotic fluphenazine hydrochloride for treating triple negative breast cancer with brain metastases and lung metastases.. PubMed. 9(3). 459–478. 41 indexed citations

12.

Feng, Zhanzhan, Yong Xia, Tiantao Gao, et al.. (2018). The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis. Cell Death and Disease. 9(10). 1006–1006. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact